Regeneron Pharmaceuticals (REGN) Receiving Somewhat Favorable News Coverage, Analysis Shows


Headlines about Regeneron Pharmaceuticals have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than 20 million news and blog sources.



from Biotech News